A Double Blind, Randomized, Placebo Controlled, Multicenter Study to Evaluate Safety, Tolerability, and Efficacy on LDL-C of study drug in Subjects with HIV and with Hyperlipidemia and/or Mixed Dyslipidemia

August 01, 2018
https://clinicaltrials.gov/ct2/show/NCT02833844
Infectious Disease
Principal Investigator: Norman P Markowitz, MD
LDL-C, HIV, Hyperlipidemia, Mixed Dyslipidemia  
Accepting Participants